Wednesday, July 9, 2025
HomeNews

News

FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

The U.S. Food and Drug Administration approved Omisirge, a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a...

Gamida Cell’s Allogeneic Cell Therapy Omisirge Receives FDA Approval

Gamida Cell Ltd, a cell therapy pioneer working to turn cells into powerful therapeutics, announced that the U.S. Food and Drug Administration (FDA) has...

NovoNutrients signs technology development agreement with Woodside Energy

NovoNutrients announced the signing of a technology development agreement under which Woodside Energy would contribute up to US$3 million to NovoNutrients, subject to the completion of...

Seeq Achieves AWS Manufacturing and Industrial Competency

Seeq Corporation, a leader in manufacturing and industrial internet of things (IoT) advanced analytics software, announced that it has achieved the Amazon Web Services...

Bruker Advances NMR Magnet Portfolio, Innovates in Industrial Solutions

At the Experimental Nuclear Magnetic Resonance Conference, Bruker announces innovations for NMR spectroscopy in life science, pharma, and cleantech research to enable discoveries in functional structural...
0FansLike
0FollowersFollow
spot_img

Hot Topics